OR WAIT null SECS
August 14, 2023
A report from the UK Bioindustry Association report indicated that biotech venture and public financing rose from £295 million in the first quarter to £382 million in the second quarter.
August 11, 2023
The guidance can help both applicants and manufacturers limit the mutagenic and carcinogenic potential of NDSRIs.
The new drug could be a powerful tool for patients suffering depressive symptoms after birth.
August 10, 2023
The site was acquired by AGC Biologics in July 2020, and the Milan location is the first cell and gene therapy site approved in Europe for GMP manufacturing of clinical and commercial supplies.
August 08, 2023
The investigational drug was developed to activate a novel uptake pathway, allowing antineoplastic drugs to combat solid tumors more successfully.
Lower levels of an active ingredient may result in unexpected pregnancies.
August 03, 2023
The nasal-spray drug can be used to reverse the effects of opioid overdose.
August 02, 2023
Only a significant joint effort across the supply chain will help to make healthcare more sustainable and reduce the impact of climate change on global health.
August 01, 2023
The program aims to aid submissions from external stakeholders and FDA staff.
The guidance document outlines recommendations to limit potential carcinogenic risk.